Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fusu Heji (中药复苏合剂) is a traditional Chinese medicine (TCM) compound formulation, typically used as a multi-herbal decoction or oral liquid. It is designed based on TCM principles and clinical experience, often formulated by medical institutions for specific indications. Fusu Heji and similar TCM compound preparations are commonly used in China to support recovery in various acute and chronic conditions, including critical illnesses such as sepsis or shock, where they may be administered alongside conventional therapies to enhance efficacy or reduce adverse effects. The exact herbal composition of Fusu Heji can vary depending on the institution but generally includes multiple herbs with purported synergistic effects according to TCM theory. The mechanism of action is considered multi-targeted and holistic from the TCM perspective; pharmacologically, it likely involves modulation of immune response, anti-inflammatory activity, organ protection, and improvement of microcirculation[1]. However, detailed molecular targets are not well characterized in Western pharmacological terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fusu heji.